Home › GERD › NCT03418350

The Role of Laryngopharyngeal Reflux in IPF

Who can join

Ages 40 to 95 · All sexes

Inclusion Criteria:

* Diagnosis of IPF
* Age 40-95
* Able to read, speak, and understand English
* If subjects are currently taking medication for reflux or GERD, they much be on a stable does for at least 4 weeks prior to consent.

Exclusion Criteria:

* Patients who do not meet all inclusion criteria
* Pregnant females

About the study

The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).

Sponsor: National Jewish Health · Participants: 60 · Started: Aug 1, 2018

Contact the study team

• Matthew Koslow, MPH · Phone: 303-398-1996

Official record on ClinicalTrials.gov — NCT03418350

Locations in the U.S.

Conditions

• GERD

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.